BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carbonneau M, Davyduke T, Spiers J, Brisebois A, Ismond K, Tandon P. Patient Views on Advance Care Planning in Cirrhosis: A Qualitative Analysis. Can J Gastroenterol Hepatol 2018;2018:4040518. [PMID: 30079330 DOI: 10.1155/2018/4040518] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Kotha S, Berry P. The writing was on the wall: Decision making near the end of life in advanced liver disease. Progress in Palliative Care. [DOI: 10.1080/09699260.2022.2067702] [Reference Citation Analysis]
2 Rogal SS, Hansen L, Patel A, Ufere NN, Verma M, Woodrell CD, Kanwal F. AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology 2022. [PMID: 35103995 DOI: 10.1002/hep.32378] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Siden EG, Carter RZ, Barwich D, Hassan E. Part of the solution: A survey of community organisation perspectives on barriers and facilitating actions to Advance Care Planning in British Columbia, Canada. Health Expect 2021. [PMID: 34904336 DOI: 10.1111/hex.13390] [Reference Citation Analysis]
4 Patel AA, Woodrell C, Ufere NN, Hansen L, Tandon P, Verma M, Lai J, Pinotti R, Rakoski M; Palliative Care Education, Advocacy, and Research in Liver Disease (PEARL) Workgroup and the AASLD Public Health / Healthcare Delivery Special Interest Group (SIG). Developing Priorities for Palliative Care Research in Advanced Liver Disease: A Multidisciplinary Approach. Hepatol Commun 2021;5:1469-80. [PMID: 34510839 DOI: 10.1002/hep4.1743] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Deng LX, Tana MM, Lai J. Thinking Ahead: Advance Care Planning for Patients With Cirrhosis. Clinical Liver Disease 2022;19:7-11. [DOI: 10.1002/cld.1157] [Reference Citation Analysis]
6 Poyner C, Tripathi D, Mathers J. Exploring patients' perceptions and experiences of treatments for the prevention of variceal bleeding: a qualitative study. BMJ Open Gastroenterol 2021;8:e000684. [PMID: 34400438 DOI: 10.1136/bmjgast-2021-000684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Das D, Ali M, Hussain IA, Ingram JTN, Johnstone RS, Lopes JJ, Wadee T, Chakraborty N. What do we know about patients' perspectives and expectations relating to palliative and end-of-life care in advanced liver disease? A systematic review of qualitative literature using ENTREQ guidelines. BMJ Support Palliat Care 2021:bmjspcare-2021-003057. [PMID: 34233896 DOI: 10.1136/bmjspcare-2021-003057] [Reference Citation Analysis]
8 Patel AA, Ryan GW, Tisnado D, Chuang E, Walling AM, Saab S, Khemichian S, Sundaram V, Brook RH, Wenger NS. Deficits in Advance Care Planning for Patients With Decompensated Cirrhosis at Liver Transplant Centers. JAMA Intern Med 2021;181:652-60. [PMID: 33720273 DOI: 10.1001/jamainternmed.2021.0152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
9 Rakoski MO, Volk ML. Palliative care and end-stage liver disease: a critical review of current knowledge. Curr Opin Gastroenterol 2019;35:155-60. [PMID: 30925536 DOI: 10.1097/MOG.0000000000000530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Laube R, Sabih AH, Strasser SI, Lim L, Cigolini M, Liu K. Palliative care in hepatocellular carcinoma.J Gastroenterol Hepatol. 2021;36:618-628. [PMID: 32627853 DOI: 10.1111/jgh.15169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
11 Wang CW, Lebsack A, Sudore RL, Lai JC. Low Rates of Advance Care Planning (ACP) Discussions Despite Readiness to Engage in ACP Among Liver Transplant Candidates. Dig Dis Sci 2021;66:1446-51. [PMID: 32500286 DOI: 10.1007/s10620-020-06369-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
12 Verma M, Tapper EB, Singal AG, Navarro V. Nonhospice Palliative Care Within the Treatment of End-Stage Liver Disease. Hepatology 2020;71:2149-59. [PMID: 32167615 DOI: 10.1002/hep.31226] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
13 Jakab SS, Verma M, Navarro V, Taddei TH. Palliative Care in Cirrhosis: Beyond Misconceptions. Curr Treat Options Gastro 2020;18:245-54. [DOI: 10.1007/s11938-020-00283-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Woodland H, Hudson B, Forbes K, McCune A, Wright M; British Association for the Study of the Liver (BASL) End of Life Special Interest Group. Palliative care in liver disease: what does good look like? Frontline Gastroenterol 2020;11:218-27. [PMID: 32419913 DOI: 10.1136/flgastro-2019-101180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]